The move was the first large acquisition by the health system, one devised to expand its scope to eastern Macomb County and into Detroit to attract new patients and revenue.
J&J is exploring a plan to offload liabilities from widespread Baby Powder litigation into a newly created business that would then seek bankruptcy protection. The company has not yet decided whether to pursue the bankruptcy plan and could ultimately abandon the idea, sources told Reuters. J&J faces legal actions from tens of thousands of plaintiffs alleging its Baby Powder and other talc products contained asbestos and caused cancer.
Democrats on the Senate Budget Committee agreed to roughly $3.5 trillion in spending for their broad healthcare and antipoverty plan, determining the scope of the party’s expected efforts on education, climate change, child care and a host of other issues while it has control of Congress and the White House. Senate Majority Leader Chuck Schumer (D., N.Y.) announced the agreement Tuesday night after an hourslong meeting among White House officials and members of the committee, which is tasked with crafting the broad contours of the bill.
A knock came on the door of Hope Cantwell’s East Nashville apartment early this year. She still hadn’t been vaccinated and says she wasn’t really answering the door to strangers. So she didn’t. But then several more attempts came over the course of a week. Eventually she masked up and opened. A legal assistant handed her a summons to appear in court. "I couldn’t believe someone — someone? a corporation? a company? — was doing this during a pandemic," Cantwell says. It started with a hospital visit in May 2019. Cantwell was referred to the Tennova Healthcare-Lebanon facility owned at the time by Community Health Systems, a publicly traded company based in Franklin.
Medicare spent billions more money on generic drugs for its beneficiaries than warehouse chain Costco did for the same drugs, according to an analysis published Tuesday. This overspending hit $2.6 billion in 2018, Erin Trish, associate director of the University of Southern California's Schaeffer Center for Health Policy and Economics, and colleagues wrote in a letter to the Journal of the American Medical Association's JAMA internal Medicine.